The Effects of Self-monitoring With a Mobile Application in Heart Failure
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 45 - Any |
| Updated: | 5/25/2018 |
| Start Date: | March 6, 2017 |
| End Date: | April 30, 2019 |
| Contact: | Judith Grossi |
| Email: | jgrossi@med.umich.edu |
| Phone: | 734-232-6367 |
A Patient-centered Mobile Intervention to Promote Self-management and Improve Patient Outcomes in Chronic Heart Failure
In the United States, about 40 percent of heart failure (HF) patients are readmitted within
1-year following their first admission for HF and hospitalization accounts for approximately
70 percent of the costs of HF management. As a result, the management of HF patients is
evolving from the traditional model of face-to-face follow-up visits toward a proactive
real-time technological model of assisting patients with monitoring and self-management while
in the community. The investigators plan to test the impact of a mobile application on
clinical outcomes in HF.
1-year following their first admission for HF and hospitalization accounts for approximately
70 percent of the costs of HF management. As a result, the management of HF patients is
evolving from the traditional model of face-to-face follow-up visits toward a proactive
real-time technological model of assisting patients with monitoring and self-management while
in the community. The investigators plan to test the impact of a mobile application on
clinical outcomes in HF.
HF patients with a reduced ejection fraction will be randomized to the mobile application
versus placebo for 12 weeks. The mobile application will provide the participants with a
reminder to perform self-monitoring, a health status indicator and heart failure education
for self-management.
All participants will complete the Minnesota Living with Heart Failure Questionnaire and
Self-Care Heart Failure Index. Hospital admissions and mortality will also be collected.
versus placebo for 12 weeks. The mobile application will provide the participants with a
reminder to perform self-monitoring, a health status indicator and heart failure education
for self-management.
All participants will complete the Minnesota Living with Heart Failure Questionnaire and
Self-Care Heart Failure Index. Hospital admissions and mortality will also be collected.
Inclusion Criteria:
- 45 years old or older
- Left ventricular ejection fraction 40% (with left atrial size
>40mm or BNP > 200 pg/ml or NT-proBNP > 800 pg/ml)
- Admitted for acutely decompensated heart failure or recently discharged in the past 4
weeks.
- Smartphone (iOS or Android) with home wifi
Exclusion Criteria:
- Unstable coronary syndrome within 8 weeks (unstable angina, NSTEMI, STEMI)
- Primary valvular heart disease
- Known pericardial disease (Sarcoidosis, amyloidosis, rheumatoid arthritis, lupus)
- Uncorrected thyroid disease
- Advanced renal disease (dialysis or creatinine >4.0 mg/dL)
- End-stage HF (hospice candidate, home milrinone or dobutamine)
- Active cancer
- Pulmonary fibrosis
- Discharge to a setting other than home
We found this trial at
2
sites
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
Ann Arbor, Michigan 48109
(734) 936-4000
University of Michigan Health System The University of Michigan is home to one of the...
Click here to add this to my saved trials